Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Mind Medicine (MNMD) Announces Proposed Stock Offering, Size not Disclosed
-
MindMed Announces Proposed Public Offering of Common Shares
-
SEC Charges 16 Wall Street Firms with Widespread Recordkeeping Failures
-
Form SC 13G Hennessy Capital Investm Filed by: CANTOR FITZGERALD SECURITIES
-
SEC Charges 16 Wall Street Firms with Widespread Recordkeeping Failures
-
Twitter, JetBlue, Lucid Group Rise Premarket; Avidity, Ferguson Fall
-
Cantor Fitzgerald Initiates Lucid Group (LCID) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Lucid Group Inc. (LCID) at Overweight
-
Cantor Fitzgerald Keeps $15 PT on Roivant Sciences (ROIV), 'Keep It Top Of Mind, Highly Anticipated Phase 3 AD Data Coming 1H23'
-
NioCorp to Combine with Nasdaq-Listed GXII (GXII) to Access Additional Capital for the Elk Creek Critical Minerals Project
-
Aravive to Participate in the Cantor Fitzgerald Oncology & HemOnc Conference
-
HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference
-
NioCorp to Combine with Nasdaq-Listed GXII to Access Additional Capital for the Elk Creek Critical Minerals Project
-
Actinium to Present at the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference
-
Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) Is ‘One to Watch’
-
Jasper Therapeutics to Present at Upcoming Conferences
-
Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences
-
PDS Biotech to Participate at Cantor Fitzgerald’s Oncology & HemOnc Conference
-
Form SC 13G PORTAGE FINTECH ACQUISIT Filed by: CANTOR FITZGERALD SECURITIES
-
Cantor Fitzgerald and Silverstein Properties Announce the Closing of a $176 Million Construction Loan for Astra Tower in Salt Lake City
-
AVEO Oncology Announces Participation at the Cantor Fitzgerald Oncology & HemOnc Conference
-
Form DEF 14A Cantor Fitzgerald Income For: Nov 16
-
Rumble (RUM) Stock To Begin Trading Under Ticker Symbol "RUM"
-
Rumble Stock To Begin Trading Under Ticker Symbol RUM, a Symbol of Freedom
-
OncoNano Medicine to Present at Cantor Fitzgerald Oncology & HemOnc Conference
-
UPDATE: Cantor Fitzgerald Starts AgileThought Inc. (AGIL) at Overweight
-
Form 424B3 Cantor Fitzgerald Income
-
Rumble and CF Acquisition Corp. VI (CFVI) Complete Business Combination
-
Rumble Completes Business Combination with CF Acquisition Corp. VI
-
Space tech startup Intuitive Machines seeks U.S. listing via $1 billion SPAC deal
-
Intuitive Machines to List on Nasdaq Through Merger with Inflection Point Acquisition Corp. (IPAX)
-
Intuitive Machines, a Leading Space Exploration Company, to List on Nasdaq Through Merger with Inflection Point Acquisition Corp.
-
FOXO Technologies (DWIN) Completes Merger, to List Under Ticker "FOXO"
-
Longevity Science Leader FOXO Technologies Inc. to List on NYSE American Following Successful Business Combination with Delwinds Insurance Acquisition Corp.
-
CF Acquisition Corp. VI (CFVI) Announces Stockholder Approval of the Proposed Combination with Rumble Inc.
-
CF Acquisition Corp. VI Announces Stockholder Approval of the Proposed Combination with Rumble Inc.
-
Form SC 13G Bilander Acquisition Filed by: CANTOR FITZGERALD SECURITIES
-
Stock market tumble draws bargain hunters
-
Clear Street Expands Institutional Sales Footprint with Several Senior Hires
-
Rumble (CFVI) Announces Post-Merger Board of Directors
-
Rumble's Post-Merger Board of Directors
-
Conversation with Chris Pavlovski, CEO of Rumble and Howard W. Lutnick, CEO of Cantor Fitzgerald and CFVI
-
Abeona Therapeutics to Participate in the Cantor Fitzgerald Cell and Genetic Medicines Conference
-
Abeona Therapeutics to Participate in the Cantor Fitzgerald Cell and Genetic Medicines Conference
-
Orchid Island Capital Announces September 2022 Monthly Dividend and August 31, 2022 RMBS Portfolio Characteristics
-
CIM Group Expands Investment in Renewable Natural Gas with Acquisition of MAS Energy’s RNG Development Platform
-
Selecta Biosciences to Participate in Upcoming Investor Conferences
-
Excision BioTherapeutics to Present at Upcoming Conferences
-
DA Davidson Initiates Coverage on Rumble SPAC (CFVI) With Buy Rating and $15 Price Target
-
Cantor Fitzgerald Initiates Coverage of Cyber Stocks - Starts CrowdStrike at Overweight

